All Change in the Advanced Wound Care Market 2009 : Market Research Report

All Change in the Advanced Wound Care Market 2009

Published by: Espicom Healthcare Intelligence

Published: May. 27, 2009 - 236 Pages

EXECUTIVE SUMMARY
OVERVIEW: Wound Care Products; Advanced Wound Care Products; Complex Wounds: The Role of Advanced Wound Care; Diabetic Ulcers; Pressure Ulcers; Venous Stasis Ulcers
ADVANCED WOUND CARE MARKET COMPETITORS: Select Manufacturers’ Wound Care Sales, 2003-2008 (US$ million); Companies’ Wound Care Sales Growth, 2007-2008 (US$ million unless stated)
ADVANCED WOUND CARE MARKET DYNAMICS: Professional Wound Care Market by Product, 2007-2013 (US$ million); Global Wound Care Market Growth by Product, 2008-2013 (%); Regional Perspective; Advanced Wound Care Market by Region, 2007-2013 (US$ million); Advanced Wound Care Market Growth by Region, 2007-2013 (%); Changing Industry Landscape; Advanced Wound Care Acquisitions, 2007-2009
ADVANCED WOUND CARE PRODUCTS & TECHNOLOGIES
DEVICE-BASED WOUND CARE: Negative Pressure Wound Therapy; Kinetic Concepts’ V.A.C. Therapy; ABThera Open Abdomen NPWT System; V.A.C. Clinical Studies; Future Developments and Market Expansion; Smith & Nephew NPWT Systems; Boehringer Technologies’ Engenex NPWT System; Genadyne Biotechnologies’ A4 NPWT System; Getinge’s WoundASSIST TNP System; Innovative Therapeutics’ Svedman and Sved Systems; Kalypto Medical’s NPD 1000 System; Medela’s Invia NPWT Systems; Premco Medical Systems’ Prodigy NPWT Systems; Prospera’s PRO NPWT Systems; Talley Group’s Venturi Systems; Electrical Stimulation; Biofisica’s POSiFECT Bio-Electric Stimulation Therapy; Ivivi Technologies’ Targeted Pulsed Electromagnetic Field Therapy; Synapse Microcurrent; Vomaris’ PROCELLERA; Ultrasound; Arobella Medical’s Qoustic Wound Therapy System; Celleration’s MIST Therapy System; HeaLFUS’ CaviClean; Misonix’ SonicOne Ultrasonic Wound Debridement System; NanoVibronix’ PainShield; Söring’s Sonoca Systems; Extracorporeal Shock Wave Therapy; SANUWAVE’s dermaPACE; Tissue Regeneration Technologies’ DermaGold; Regenesis Biomedical’s Provant Wound Therapy System; SanoMed’s Photizo Light Therapy; Vibrant Medical Vibration Therapy
MOIST WOUND CARE PRODUCTS: Moist Wound Care Market, 2007-2013 (US$ million); Moist Wound Care Market Growth, 2008-2013 (%); Hydrogels; Key Hydrogel Products and Manufacturers; New Hydrogel Technologies; AGT Sciences’ Hydrogel Technology; BioCure’s GelSpray; First Water’s Pro-ionic Gel Dressings; Nanotherapeutics NanoDOX 1% Doxycycline Monohydrate Hydrogel; Oculus Innovative Sciences’ Microcyn Hydrogel; ULURU’s Nanoflex Technology; Hydrocolloid Dressings; Key Hydrocolloid Products and Manufacturers; New Hydrocolloid Technologies; First Water’s Pro-ionic Hydrocolloid Dressings; Alginates; Key Alginate Products and Manufacturers; Foam Dressings; Key Foam Products and Manufacturers; New Foam Technologies; Coloplast’s Biatain; ConvaTec’s Versiva XC Gelling Foam Dressings; First Water’s Pro-ionic Foam Dressings; Smith & Nephew’s Allevyn Dressings; Composite Dressings; Key Composite Products and Manufacturers; 3M Tegaderm Matrix Dressing with PHI technology; Archimed’s Oxyzyme; ConvaTec’s AQUACEL Hydrofiber Dressings; Derma Sciences’ XTRASORB Super Absorbent Dressing; First Water’s Pro-ionic Matrix; Activated Charcoal Dressings; Key Charcoal Products and Manufacturers; Transparent Film Dressings; Key Transparent Film Products and Manufacturers; New Transparent Film Technologies; First Water’s Pro-ionic Film; Antimicrobial Dressings; Silver Dressings; Key Silver Products and Manufacturers; Argentum Medical’s Silverlon; AcryMed’s SilvaSorb; ConvaTec’s AQUACEL Ag; Medline’s Silver Antimicrobial Dressings; Smith & Nephew’s Acticoat Dressings; Smith & Nephew’s Algisite Ag, Allevyn Ag and Biostep Ag; Systagenix Wound Management’s Silvercel and Actisorb Silver; URGO’s UrgoCell Silver; New Silver Technologies; Honey Dressings; Advancis Medical’s Activon; Comvita’s Medihoney; Sanoskin’s SanoSkin-Melladerm; Triticum’s L-Mesitran Range; Other Antimicrobial Dressings; Iodine-based Dressings; PHMB Antimicrobial Dressings; 3M’s Tegaderm CHG; Derma Sciences’ Dermagran; Healthpoint Hydrofera Blue; Innocoll’s CollaRx Gentamicin; Oculus Innovative Sciences’ Microcyn Technology; Quick-Med Technologies’ NIMBUS
BIOLOGICS AND PHARMACEUTICALS: Collagen-Based Wound Care Products; Argentum Medical’s BIOPAD; BioCore Medical Technologies’ Kollagen; Collagen Matrix’ Matrix Collagen Dressing; Covalon Technologies’ Biostep and ColActive; Dr Suwelack Skin & Health Care’s Puracol Plus; Eucare Pharmaceuticals; Innocoll’s CollaRx Technology; Lescarden’s Catrix Wound Dressing; Pegasus Biologics’ Unite Biomatrix; Systagenix Wound Management’s Collagen-Based Dressings; Wound Management Technologies’ CellerateRx; Products in Development; Covalon Technologies; Dr Suwelack Skin & Health Care’s SHC-Matrix; Innocoll’s Collieva Ag, DermaSIL and CollaRx Lidocaine Sponge; FibroGen’s Synthetic Collagen; Skin Substitutes; ACell/Medline’s MatriStem Extracellular Matrix Wound Sheet; Advanced BioHealing’s Dermagraft; Avita Medical’s ReCell; Cook Biotech’s Oasis Wound Matrix; Dr Suwelack Skin & Health Care’s Matriderm; Fidia Advanced Biopolymers’ HYAFF; Genzyme’s Epicel Cultured Epidermal Autografts; Integra LifeSciences’ Collagen-Glycosaminoglycan Matrix; LifeCell’s AlloDerm; Medestea Internazionale’s Veloderm; Mölnlycke’s Xelma; Organogenesis’ Apligraf; Promethean LifeSciences’ GammaGraft; Tissue Genesis’ Cell Isolation System; UDL Laboratories/S&N’s Biobrane; LifeCell/Wright Medical Group’s Graftjacket and Osteoset; York Pharma’s MySkin and CryoSkin; Products in Development; Forticell Bioscience’s OrCel; Intercytex’ ICX-SKN; Organogenesis; US Armed Forces Institute of Regenerative Medicine; York Pharma’s Lyphoderm; Growth Factors; Recombinant Growth Factors; Products in Development; Plasma-Derived Growth Factors; Cytomedix’ AutoloGel System; SafeBlood Technologies’ Autologous Platelet Grafting System; Enzymatic Debriding Agents; Healthpoint’s Collagenase Santyl Ointment; Products in Development; Maggot Enzyme-based Dressing Project; Mediwound’s Debrase Gel Dressing; Novel Biologic and Pharmaceutical Products in Development; Agennix' Talactoferrin; Biotec Pharmacon’s SBG Compound; Brennen Medical’s Oat Beta-Glucan; Covalon Technologies’ EPAS-1 Project; Derma Sciences’ DSC127; HealOr’s Protein Kinase C-Based Therapeutics; ImmuneRegen BioSciences’ Homspera; Polyheal’s Microsphere-Based Technology; RegeneRx’ RGN-137; RGN-137 for Pressure Ulcers; RGN-137 for Venous Stasis Ulcers; RGN-137 for Epidermolysis Bullosa (EB); TGR BioSciences’ Tissue Regeneration Technologies
OTHER PRODUCTS: Oxygen Dressings; AcryMed’s Oxygenated Dressing; Archimed’s Oxyzyme; Oxygen Biotherapeutics’ Oxybiocyte; Sangui BioTech’s HEMO2SPRAY; Chitosan Dressings; BioSyntech’s BST-DermOn; HemCon Medical Technologies; Sangui BioTech’s Chitoskin
MANUFACTURERS
THE MARKET LEADERS: 3M; Recent Key Events; Current Alliances; Becton Dickinson; Kinetic Concepts; Greystone Pharmaceuticals; Financial Performance; 3M Health Care - Operating Results, 2005-2008 (US$ million); Latest Results and Outlook; Coloplast; Current Alliances; Smith & Nephew; Johnson & Johnson; Financial Performance; Coloplast - Operating Results, 2004-2008 (DKr million); Revenue by Product Line, 2007-2008 (DKr million); Latest Results; Outlook; ConvaTec; Recent Key Events; Current Alliances; Boehringer Technologies; HemCon Medical Technologies; Financial Performance; ConvaTec - Operating Results, 2006-2008 (US$ million); ConavTec - Revenue by Product Line, 2002-2007 (US$ million); ConvaTec Wound Therapeutics Sales by Region, 2003-2007 (US$ million); Unomedical’s Results; Unomedical - Operating Results, 2003-2007 (DKr million); Covidien; Financial Performance; Covidien - Operating Results, 2004-2008 (US$ million); Hartmann Group; Current Alliances; Indian Apollo Hospital Group and the West China Hospital; Kinetic Concepts; Financial Performance; Hartmann - Operating Results, 2004-2008 (EUR million); Hartmann Wound Management Results, 2007-2008 (EUR million); Latest Results and Outlook; Kinetic Concepts; Recent Key Events; Current Alliances; 3M; Avail Medical Products; NovaBay Pharmaceuticals; Hartmann; Wake Forest University; GPO Contracts and US Customers; Litigation; Smith & Nephew; Medela; Innovative Therapies; Mölnlycke Health Care; Boehringer Technologies and ConvaTec; Financial Performance; KCI - Operating Results, 2004-2008 (US$ million); KCI - Revenue by Product Type, 2004-2008 (US$ million); KCI - V.A.C. Revenue, 2004-2008 (US$ million); KCI - V.A.C. Revenue by Region, 2006-2008 (US$ million); Latest Results; Outlook; Medline Industries; Current Alliances; ACell; Avery Dennison Medical; AcryMed; Lohmann & Rauscher; Dr Suwelack Skin & Health Care; GPO Contracts; Mölnlycke Health Care; Current Alliances; University of Nottingham and AGT Sciences; Litigation; Kinetic Concepts; Financial Performance; Mölnlycke - Operating Results, 2006-2008 (EUR million); Smith & Nephew; Recent Key Events; Current Alliances; Coloplast; Apria Healthcare Group; Universal Hospital Services; Covalon Technologies; UDL Laboratories; Movianto Deutschland; Lescarden/Valeant Pharmaceuticals; Derma Sciences; Nucryst Pharmaceuticals; Litigation with Kinetic Concepts; Financial Performance; S&N - Operating Results, 2004-2007 (US$ million); S&N Advanced Wound Care Results, 2004-2008 (US$ million); Latest Results; Systagenix Wound Management; Other Companies; ACell; AcryMed; Financial Performance; I-Flow Operating Results by Segment, 2008 (US$ thousand); Advanced BioHealing; Advanced Medical Solutions; Current Agreements; Systagenix; B. Braun; Financial Performance; AMS Advanced Wound Care Division - Operating Results, 2005-2008 (£ thousand); Advancis Medical; Advitech; Financial Performance; Agennix; AGT Sciences; R&D Projects; Diagnostic Dressings; Antibacterial Dressings; Maggot Enzyme-based Dressing; Archimed; Argentum Medical; Ark Therapeutics; Current Agreements; Darco GmbH & Co; Flen Pharma; Runfold Medical Ltd; Sino Tau International Company Ltd; Financial Performance; Ark Therapeutics - Operating Results, 2004-2008 (£ thousand); Arobella Medical; Aspen Surgical Products; Avita Medical; Financial Performance; Avita Medical/C3 - Operating Results, 2006-2008 (A$ thousand); Avita Medical/C3 - Regenerative Medicine Results, 2074-2008 (A$ thousand); Latest Results; B. Braun; Financial Performance; B Braun - Operating Results, 2004-2008 (EUR million); BioCore Medical Technologies; BioCure; BioElectronics; Biofisica; BioSyntech; BioSyntech - Operating Results, 2005-2008 (C$); Biotec Pharmacon; Financial Performance; Biotec Pharmacon - Operating Results, 2007-2008 (NKr million); Boehringer Laboratories; Brennen Medical; Care-Tech Laboratories; Celleration; Collagen Matrix; Comvita; Financial Performance; Comvita - Operating Results, 2003-2008 (NZ$ million); Latest Results and Outlook; Concept Health/Gentell; Covalon Technologies; Recent Key Events; Financial Performance; Covalon Technologies - Operating Results, 2005-2008 (C$ million); Covalon - Revenue by Product Line, 2006-2008 (C$ thousand); Latest Results; Cytomedix; Financial Performance; Cytomedix - Operating Results, 2004-2008 (US$ thousand); DermaRite Industries; Derma Sciences; Recent Key Events; Financial Performance; Derma Sciences - Operating Results, 2005-2008 (US$ million); Derma Sciences - Wound Care Division Results, 2006-2008 (US$ million); Latest Results; DeRoyal; Diapulse Corporation of America; Dr Suwelack Skin & Health Care; Eucare Pharmaceuticals; Ferris; FibroGen; Fidia Advanced Biopolymers; First Water; Forticell Bioscience; Bankruptcy and Future Funding; Current Alliances; Lonza Walkersville; ES Cell International Pte Ltd; Teva Pharmaceutical Industries; Genadyne Biotechnologies; Genzyme Biosurgery; Getinge; Greystone Pharmaceuticals; HealOr; HeaLFUS; Healthpoint; Helix Biomedix; HemCon Medical Technologies; Recent Key Events; Current Alliances; IT/Sligo; Sangui BioTech; Nanopeutics Joint Venture; ConvaTec; Hollister Wound Care; Hydrofera; Innocoll and CollMED Laboratories; Innovative Therapies; Integra LifeSciences Holdings; Integra LifeSciences - Operating Results, 2004-2008 (US$ million); Intercytex; US Armed Forces Institute of Regenerative Medicine; IR BioSciences (ImmuneRegen BioSciences); Research Alliances; Financial Performance; Ivivi Technologies; Recent Key Events; Current Wound Care Alliances; RecoverCare; Regency Hospital Company; Indiana State University; Termination of Agreement - DSI Renal; ADM Tronics Unlimited; Financial Performance; Ivivi Technologies - Operating Results, 2006-2008 (US$ thousand); Latest Results; IYIA Technologies; Kalypto Medical; Kikgel; Kuros; Laboratoires Brothier; Lescarden; Lescarden - Operating Results, 2004-2008 (US$ thousand); Lohmann & Rauscher; Medela; Medestea Internazionale; MediWound; Milliken Chemical; Misonix; Nanotherapeutics; NanoVibronix; Noble Biomaterials; Nucryst Pharmaceuticals; Alliance with Smith & Nephew; Financial Performance; Nucryst Pharmaceuticals - Operating Results, 2004-2008 (US$ million); Latest Results; Oculus Innovative Sciences; Financial Performance; Oculus - Operating Results, 2004-2008 (US$ thousand); Oculus - Product Sales by Region, 2007-2008 (US$ thousand); Latest Results and Outlook; Organogenesis; Armed Forces Institute of Regenerative Medicine; Oxygen Biotherapeutics; Pegasus Biologics; Polyheal; Premco Medical Systems; Promethean LifeSciences; Prospera; Quick-Med Technologies; Licensing and Development Agreements; Financial Performance; Quick-Med Technologies - Operating Results, 2004-2008 (US$ thousand); Latest Results; RegeneRx Biopharmaceuticals; Financial Performance; RegeneRx - Operating Results, 2004-2008 (US$ million); Latest Results; Regenesis Biomedical; SafeBlood Technologies; Sangui BioTech International; Financial Performance; Sangui BioTech - Operating Results, 2004-2008 (US$ thousand); SanoMed Manufacturing
SANUWAVE: Söring; Southwest Technologies; Synapse Microcurrent; Talley Group; TGR BioSciences; Tissue Genesis; Tissue Regeneration Technologies; Triticum; UDL Laboratories
ULURU: York Pharma Acquisition Agreement; Financial Performance; ULURU - Operating Results, 2006-2008 (US$ million); Latest Results
URGO: Current Alliances; Advitech; Financial Performance; URGO - Operating Results, 2005-2008 (US$ million); Vibrant Medical; Vomaris; Wound Management Technologies; Financial Performance; Wound Management Technologies - Operating Results, 2004-2008 (US$ thousand); Latest Results; York Pharma; ZooBiotic
APPENDICES
APPENDIX 1 - LIST OF ABBREVIATIONS
APPENDIX 2 - REPORT METHODOLOGY: Secondary Sources; Primary Sources; Market forecasts

Abstract

The rapid progress of the NPWT sector and the exit of Johnson & Johnson and Bristol-Myers Squibb has changed this sector fundamentally. This report examines the market, product ranges and growth drivers, and provides market share data by company for major product sectors and growth forecasts to 2013. Also included are competitor reviews of 115 leading and developing companies.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports, company profiles and country profiles from over 700 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

2/14/2012 - 30

All Change in the Advanced Wound Care Market 2009

Table of Contents

Abstract